Gyre Therapeutics (GYRE) Inventory Average (2024 - 2026)
Gyre Therapeutics (GYRE) reported Inventory Average of $10.8 million for Q1 2026, up 51.41% year-over-year from $7.1 million in Q1 2025, and up 13.13% on a QoQ basis from $9.5 million in Q4 2025.
Gyre Therapeutics (GYRE) has 3 years of Inventory Average data on file, last reported at $10.8 million in Q1 2026.
- Quarterly Inventory Average rose 51.41% year-over-year to $10.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.8 million (up 51.41% YoY) and the FY2025 annual result came in at $8.3 million, up 55.47% from the prior year.
- Inventory Average climbed to $10.8 million in Q1 2026 per GYRE's latest filing, from $9.5 million in the prior quarter.
- Across five years, Inventory Average topped out at $10.8 million in Q1 2026 and bottomed at $4.6 million in Q1 2024.
- The 3-year median for Inventory Average is $7.1 million (2025), against an average of $7.4 million.
- Peak annual rise in Inventory Average reached 58.3% in 2025, while the deepest fall reached 47.45% in 2025.
- Tracing GYRE's Inventory Average over 3 years: stood at $6.4 million in 2024, then jumped by 49.61% to $9.5 million in 2025, then climbed by 13.13% to $10.8 million in 2026.
- Per Business Quant, the three latest GYRE Inventory Average figures stand at $10.8 million (Q1 2026), $9.5 million (Q4 2025), and $8.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 30.59 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.73 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.15 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 83.37 Mn |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn | 10.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.76 Mn |
| Dec 31, 2025 | 9.51 Mn |
| Sep 30, 2025 | 8.86 Mn |
| Jun 30, 2025 | 8.37 Mn |
| Mar 31, 2025 | 7.11 Mn |
| Dec 31, 2024 | 6.36 Mn |
| Sep 30, 2024 | 6.01 Mn |
| Jun 30, 2024 | 5.29 Mn |
| Mar 31, 2024 | 4.61 Mn |